Internet-based patient– primary care physician–cardiologist integrated management model of hypertension in China: study protocol for a multicentre randomised controlled trial
Open Access
- 16 October 2020
- Vol. 10 (10), e039447
- https://doi.org/10.1136/bmjopen-2020-039447
Abstract
Introduction The control rate of hypertension is low in China, especially in rural, western and minority areas. This is related to poor medical skills among physicians in primary care institutions and low levels of trust among patients. However, primary healthcare institutions are the main battleground for the prevention and treatment of hypertension. It is worth exploring how to most effectively integrate patients, primary care physicians and cardiologists in tertiary hospitals, to build a long-term mechanism for the prevention and treatment of hypertension. In this study, we aim to evaluate the clinical effectiveness and conduct a health economic evaluation of an internet-based patient–primary care physician–cardiologist integrated management model of hypertension in areas of China with different socioeconomic levels. Methods and analysis This is a 12-month, multicentre, randomised controlled trial involving patients with hypertension in urban communities and rural areas of Sichuan Province, China. Each primary healthcare institution will cooperate with their tertiary hospital through the Red Shine Chronic Disease Management System (RSCDMS). Patients will be randomly assigned 1:1 to two groups: (1) a traditional care group; (2) an intervention group in which primary care physicians and cardiologists can share patient data and manage patients together through the RSCDMS. Patients can upload their blood pressure (BP) values and communicate with physicians using the system. The primary outcome is the change in systolic BP over a 12-month period. Secondary outcomes are changes in diastolic BP, BP control rate, values of 24-hour ambulatory BP monitoring, difference in cost-effectiveness between the groups, patient satisfaction, medication adherence and home BP monitoring compliance. All data will be recorded and stored in the RSCDMS and analysed using IBM SPSS V.26.0. Ethics and dissemination This study has been approved by the Biomedical Research Ethics Committee of the West China Hospital of Sichuan University in Sichuan, China (No. 2020-148). Written informed consent will be obtained from all participants. The results of this study will be disseminated to the public through academic conferences and peer-reviewed journals. Trial registration number ChiCTR2000030677.This publication has 27 references indexed in Scilit:
- Community-based interventions in hypertensive patients: a comparison of three health education strategiesBMC Public Health, 2015
- The current status and challenges of community general practitioner system building in ChinaQJM: An International Journal of Medicine, 2014
- Comprehensive Approach for Hypertension Control in Low-Income Populations: Rationale and Study Design for the Hypertension Control Program in ArgentinaThe American Journal of the Medical Sciences, 2014
- Telemonitoring can assist in managing cardiovascular disease in primary care: a systematic review of systematic reviewsBMC Family Practice, 2014
- Effect of Home Blood Pressure Telemonitoring and Pharmacist Management on Blood Pressure ControlJAMA, 2013
- Reducing Blood Pressure With Internet-Based Interventions: A Meta-analysisCanadian Journal of Cardiology, 2013
- Community-Based Programs to Improve Prevention and Management of Hypertension: Recent Canadian Experiences, Challenges, and OpportunitiesCanadian Journal of Cardiology, 2013
- Clinical usefulness and cost effectiveness of home blood pressure telemonitoringJournal of Hypertension, 2013
- SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical TrialsAnnals of Internal Medicine, 2013
- Cardiovascular protection and blood pressure reduction: a meta-analysisThe Lancet, 2001